For decades, U.S. financial markets have been widely considered one of the world’s most attractive destinations for investor ...

Many ETFs and stock pros use artificial intelligence to get an edge. But most still don’t outperform their benchmark.

Follow all the latest U.S. market action for Wednesday here to see if stocks can extend the bull run to fresh highs even as ...

The iconic canned fruits-and-vegetables brand has struggled to keep up with the changing grocery landscape, experts say.

Weaker labor-market data this week could bolster the case for the Federal Reserve to resume interest-rate cuts soon. “My view ...

The chip maker is reportedly considering not offering its 18A node externally because it has been unsuccessful in attracting ...

The real-estate industry is battling it out over control of for-sale listings, and home sellers in particular could get hurt.

As White House officials including the president escalate attacks on the central-bank chair, the director of the Federal ...

Have an issue with your financial planner or looking for a new one? Email questions or concerns to [email protected].

Did the U.S. economy really lose jobs in June for the first time since the pandemic? Payroll king ADP says yes, but investors ...

Move over tariffs. Investors have a new top concern as the second half of the year kicks off.

Top Create Biotech has filed for an initial public offering. The biotechnology company said Wednesday that it intends to list shares under the ticker symbol TCBG on the Nasdaq Capital Market. Top ...